Fig. 3From: Complete remission of alpha-fetoprotein-producing gastric cancer by combined tislelizumab-apatinib treatment of a patient with proficient mismatch repair: a case reportConcentrations of the tumor markers carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP)Back to article page